InKine Pharmaceutical Company, Inc. – Trademark Portfolio

Entity Type: 03

InKine Pharmaceutical Company, Inc. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 18 filings in this category. The owner is based in Morrisville, NC.

1700 Perimeter Park Drive

Morrisville, NC 27560

18 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ALI-PAK
ALI-PAK
Abandoned 2005
CLEN-PAK
CLEN-PAK
Abandoned 2005
OSMAXIM
OSMAXIM
Abandoned 2005
OSMAXUS
OSMAXUS
Abandoned 2005
OSMAX
OSMAX
Abandoned 2005
ALIZACT
ALIZACT
Abandoned 2004
CLENTIRA
CLENTIRA
Abandoned 2004
ALICLEEN
ALICLEEN
Abandoned 2004
CLENMAX
CLENMAX
Abandoned 2004
LUMAX
LUMAX
Abandoned 2004
ENDOMAX
ENDOMAX
Abandoned 2004
IB-STAT
IB-STAT
Cancelled 2001
HEMATROL
HEMATROL
Abandoned 2000
COLIREST
COLIREST
Abandoned 2000
VISICOL
VISICOL
Cancelled 2000
VUCOL
VUCOL
Abandoned 2000
DIACOL
DIACOL
Abandoned 1999
IK
IK
Cancelled 1998

Trademark Classifications

InKine Pharmaceutical Company, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (18 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does InKine Pharmaceutical Company, Inc. have?

InKine Pharmaceutical Company, Inc. has 18 U.S. trademarks filed with the USPTO.

What trademark classes does InKine Pharmaceutical Company, Inc. file in?

InKine Pharmaceutical Company, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is InKine Pharmaceutical Company, Inc.'s trademark registration success rate?

InKine Pharmaceutical Company, Inc. has a 0% trademark registration rate, with 0 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.